AnPac Bio-Medical Science Co., Ltd. Operating Expenses 2011-2026 | ANPC

Annual Operating Expenses AnPac Bio-Medical Science Co., Ltd.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	106 M	93.9 M	48.2 M	42.7 M	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
106 M	42.7 M	72.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	338 M	$ 220.01	2.07 %	$ 5 B	Danmark
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 19.69	2.39 %	$ 920 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 55.38	2.38 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.35	1.89 %	$ 344 M	Britain
Corbus Pharmaceuticals Holdings CRBP	85.3 M	$ 8.24	0.67 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	668 M	$ 47.3	1.87 %	$ 4.25 B	Schweiz
Cyclacel Pharmaceuticals CYCC	12 M	-	-5.98 %	$ 34.1 M	USA
CytomX Therapeutics CTMX	98.6 M	$ 4.39	3.42 %	$ 606 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	189 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	43.6 M	$ 24.37	6.1 %	$ 656 M	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.54	5.29 %	$ 870 M	Canada
Homology Medicines FIXX	36.8 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	142 M	-	-	$ 384 M	Britain